Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BAX
BBIO
Add up to 3 more stocks
BAX
Baxter International Inc.
+3.11%
$24.22+0.73Delayed quote: Oct 5, 2026, 4:00 PM EDT
Market Cap
$12.52B
52W Range
$15.73 - $30.00
BBIO
BridgeBio Pharma, Inc.
-1.65%
$66.14-1.11Delayed quote: Oct 5, 2026, 4:00 PM EDT
Market Cap
$12.95B
52W Range
$52.75 - $93.42
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | 11.79 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.02 | N/A |
| P/S Ratio | 1.09 | 18.17 |
| P/FCF Ratio | 18.47 | N/A |
| EV/EBITDA | 29.51 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 30.1% | 93.3% |
| Operating Margin | -2.4% | -113.3% |
| Net Margin | -9.3% | -97.6% |
| ROE | -17.1% | N/A |
| ROA | -5.4% | -57.2% |
| ROIC | -1.6% | -62.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.95 | 1.23 |
| Quick Ratio | 1.32 | 1.17 |
| Debt/Equity | 1.56 | N/A |
| Interest Coverage | -1.06 | -10.72 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 0.2% | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.